share_log

Embecta Analyst Ratings

Benzinga ·  Jul 18, 2023 10:06
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/18/2023 -5.59% Morgan Stanley $29 → $19 Maintains Underweight
05/15/2023 44.1% Morgan Stanley $28 → $29 Maintains Underweight
01/06/2023 39.13% Morgan Stanley → $28 Downgrades Equal-Weight → Underweight
12/21/2022 54.04% Morgan Stanley $33 → $31 Maintains Equal-Weight
10/11/2022 63.98% Morgan Stanley $36 → $33 Maintains Equal-Weight
09/08/2022 BTIG Initiates Coverage On → Neutral
08/16/2022 78.88% Morgan Stanley $33 → $36 Maintains Equal-Weight
08/01/2022 63.98% Morgan Stanley → $33 Initiates Coverage On → Equal-Weight
06/21/2022 24.22% B of A Securities → $25 Initiates Coverage On → Underperform

What is the target price for Embecta (EMBC)?

The latest price target for Embecta (NASDAQ: EMBC) was reported by Morgan Stanley on July 18, 2023. The analyst firm set a price target for $19.00 expecting EMBC to fall to within 12 months (a possible -5.59% downside). 8 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Embecta (EMBC)?

The latest analyst rating for Embecta (NASDAQ: EMBC) was provided by Morgan Stanley, and Embecta maintained their underweight rating.

When is the next analyst rating going to be posted or updated for Embecta (EMBC)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Embecta, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Embecta was filed on July 18, 2023 so you should expect the next rating to be made available sometime around July 18, 2024.

Is the Analyst Rating Embecta (EMBC) correct?

While ratings are subjective and will change, the latest Embecta (EMBC) rating was a maintained with a price target of $29.00 to $19.00. The current price Embecta (EMBC) is trading at is $20.13, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment